과학조사관

U.S. Food and Drug Administration

임상약리심사관/팀장

U.S. Food and Drug Administration

선임연구원/임상팀장

럭키바이오텍연구소

규제입증위원회 위원

식품의약품안전처

부회장

한국FDC규제과학회

중앙약사심의위원회 위원

식품의약품안전처

의약품심사 자문위원

식품의약품안전평가원

이사

한국희귀질환재단

Optimization of Radotinib Doses for the Treatment of Chronic Myelogenous Leukemia Based on Dose-Response Relationship Analysis

Antimicrobials for the Treatment of Drug-Resistant Acinetobacter Baumannii Pneumonia in Critically Ill Patients: A Systemic Review and Bayesian Network Meta-Analysis

Ph.D.

미국 피츠버그대학교 약학대학

Pharm.D.

미국 미네소타대학교 약학대학

약학석사

서울대학교 약학대학

drug monitoring of everolimus in patients who have undergone liver transplant

Orphan drug designation: a comparison of regulatory systems among United States, European Union, and Republic of Korea

Appropriate starting dose of dasatinib based on the analyses of dose limiting toxicities and molecular responses in Asian patients with chronic myeloid leukemia

Development of a limited sampling strategy for the estimation of isoniazid exposure considering N-acetyltransferase 2 genotypes in Korean patients with tuberculosis

Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia

Population pharmacokinetics of vactosertib, a new new TGF-β receptor type I inhibitor, in patients with advanced solid tumors

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study

Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia

Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of antituberculosis drug-induced liver injury: a systematic review and meta-analysis